It is an enterprise with a full technological cycle of production of genetically engineered insulins - from substances to finished dosage forms. More than 20 years of experience in research and production of medicines. Production of the whole range of recombinant human insulin preparations by our technology. Quality of products trusted by patients and partners in Europe, CIS, Brazil, Syrian Arab Republic, Yemen, and other countries. The company's development strategy envisages expanding its product portfolio with new medicines and medical devices to fully meet the needs of people living with diabetes, HIV / AIDS, and tuberculosis.